Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on July 30, 2025
The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million, resulting in a cumulative increase in carrying value of …
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results …
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Capilea Mexico Celebrates 11,550 Successful Hair Graft Patients, Highlighting Mexico as a Safe Premier Destination for Hair Transplants
Tijuana, BC , July 30, 2025 (GLOBE NEWSWIRE) -- Capilea Mexico, a leader in international hair restoration with over 25 years of experience, announced today it has successfully treated more than 11,550 hair graft patients. This milestone underscores Mexico …
STERIS Raises Dividend to $0.63 per share
DUBLIN, IRELAND, July 30, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.63 per share. This represents a $0.06 increase in the dividend and the …
VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation’s leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE: CHE), today announced that Nicholas M. Westfall will step down as …
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …
Legal Bodybuilding SARMS: Why More Pro Lifters in 2025 Trust CrazyBulk’s Safe Alternatives to Gain Muscle, Increase Strength and Cutting
New York City, NY, July 30, 2025 (GLOBE NEWSWIRE) -- CrazyBulk is leading the 2025 muscle-building evolution with what many experts consider the best SARMs for cutting and bulking legally available - no injections, no dangerous side effects, just powerful, …
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025
NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …
WeightWatchers Schedules Second Quarter 2025 Earnings Conference Call
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the second quarter 2025 ended June 30, 2025, before market open on Tuesday, August 5, 2025. …
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …
Merit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance
Highlights† Reported revenue of $382.5 million, up 13.2% Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%, respectively GAAP operating margin of 12.3%, compared to 13.6% in prior year period Non-GAAP operating margin* …
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the company will host a conference call and webcast on Wednesday, August 6, 2025 at 4:30 p.m. ET to discuss updated clinical data …
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its second quarter 2025 financial results will be released before market open on August 6, 2025. MannKind will host a …
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients
iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens clinical utility for dd-cfDNA with …
Codexis to Report Second Quarter 2025 Financial Results on August 13
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results …
Lytus Fintech Expands NexFi Platform with XRP Integration, Unlocking New Revenue Streams and Global Liquidity
Dubai, UAE, July 30, 2025 (GLOBE NEWSWIRE) -- Lytus Fintech, a business unit of Lytus Technologies Holdings PTV Ltd. (OTCMKTS: LYTHF) today announced the launch of its integration and support of XRP with its flagship digital wallet platform NexFi, to …
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
JUPITER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use …
Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics
Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted …